Global Glial Cell Line Derived Neurotrophic Factor Market Research Report 2023

Report ID: 1978029 | Published Date: Jan 2025 | No. of Page: 69 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Glial Cell Line Derived Neurotrophic Factor Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 GSK-812
        1.2.3 LAUR-301
        1.2.4 TW-002
        1.2.5 AMT-090
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Glial Cell Line Derived Neurotrophic Factor Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Amyotrophic Lateral Sclerosis
        1.3.3 Brain Ischemia
        1.3.4 Parkinson's Disease
        1.3.5 Retinal Degeneration
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Glial Cell Line Derived Neurotrophic Factor Market Perspective (2017-2028)
    2.2 Glial Cell Line Derived Neurotrophic Factor Growth Trends by Region
        2.2.1 Glial Cell Line Derived Neurotrophic Factor Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Glial Cell Line Derived Neurotrophic Factor Historic Market Size by Region (2017-2022)
        2.2.3 Glial Cell Line Derived Neurotrophic Factor Forecasted Market Size by Region (2023-2028)
    2.3 Glial Cell Line Derived Neurotrophic Factor Market Dynamics
        2.3.1 Glial Cell Line Derived Neurotrophic Factor Industry Trends
        2.3.2 Glial Cell Line Derived Neurotrophic Factor Market Drivers
        2.3.3 Glial Cell Line Derived Neurotrophic Factor Market Challenges
        2.3.4 Glial Cell Line Derived Neurotrophic Factor Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Glial Cell Line Derived Neurotrophic Factor Players by Revenue
        3.1.1 Global Top Glial Cell Line Derived Neurotrophic Factor Players by Revenue (2017-2022)
        3.1.2 Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Players (2017-2022)
    3.2 Global Glial Cell Line Derived Neurotrophic Factor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Glial Cell Line Derived Neurotrophic Factor Revenue
    3.4 Global Glial Cell Line Derived Neurotrophic Factor Market Concentration Ratio
        3.4.1 Global Glial Cell Line Derived Neurotrophic Factor Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Glial Cell Line Derived Neurotrophic Factor Revenue in 2021
    3.5 Glial Cell Line Derived Neurotrophic Factor Key Players Head office and Area Served
    3.6 Key Players Glial Cell Line Derived Neurotrophic Factor Product Solution and Service
    3.7 Date of Enter into Glial Cell Line Derived Neurotrophic Factor Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Glial Cell Line Derived Neurotrophic Factor Breakdown Data by Type
    4.1 Global Glial Cell Line Derived Neurotrophic Factor Historic Market Size by Type (2017-2022)
    4.2 Global Glial Cell Line Derived Neurotrophic Factor Forecasted Market Size by Type (2023-2028)
5 Glial Cell Line Derived Neurotrophic Factor Breakdown Data by Application
    5.1 Global Glial Cell Line Derived Neurotrophic Factor Historic Market Size by Application (2017-2022)
    5.2 Global Glial Cell Line Derived Neurotrophic Factor Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Glial Cell Line Derived Neurotrophic Factor Market Size (2017-2028)
    6.2 North America Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2017-2022)
    6.3 North America Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Glial Cell Line Derived Neurotrophic Factor Market Size (2017-2028)
    7.2 Europe Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2017-2022)
    7.3 Europe Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size (2017-2028)
    8.2 Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2017-2022)
    8.3 Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Glial Cell Line Derived Neurotrophic Factor Market Size (2017-2028)
    9.2 Latin America Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2017-2022)
    9.3 Latin America Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size (2017-2028)
    10.2 Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2017-2022)
    10.3 Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 GlaxoSmithKline Plc
        11.1.1 GlaxoSmithKline Plc Company Detail
        11.1.2 GlaxoSmithKline Plc Business Overview
        11.1.3 GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Introduction
        11.1.4 GlaxoSmithKline Plc Revenue in Glial Cell Line Derived Neurotrophic Factor Business (2017-2022)
        11.1.5 GlaxoSmithKline Plc Recent Development
    11.2 Treeway BV
        11.2.1 Treeway BV Company Detail
        11.2.2 Treeway BV Business Overview
        11.2.3 Treeway BV Glial Cell Line Derived Neurotrophic Factor Introduction
        11.2.4 Treeway BV Revenue in Glial Cell Line Derived Neurotrophic Factor Business (2017-2022)
        11.2.5 Treeway BV Recent Development
    11.3 UniQure NV
        11.3.1 UniQure NV Company Detail
        11.3.2 UniQure NV Business Overview
        11.3.3 UniQure NV Glial Cell Line Derived Neurotrophic Factor Introduction
        11.3.4 UniQure NV Revenue in Glial Cell Line Derived Neurotrophic Factor Business (2017-2022)
        11.3.5 UniQure NV Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Glial Cell Line Derived Neurotrophic Factor Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of GSK-812
    Table 3. Key Players of LAUR-301
    Table 4. Key Players of TW-002
    Table 5. Key Players of AMT-090
    Table 6. Key Players of Others
    Table 7. Global Glial Cell Line Derived Neurotrophic Factor Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Glial Cell Line Derived Neurotrophic Factor Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Glial Cell Line Derived Neurotrophic Factor Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Glial Cell Line Derived Neurotrophic Factor Market Share by Region (2017-2022)
    Table 11. Global Glial Cell Line Derived Neurotrophic Factor Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Glial Cell Line Derived Neurotrophic Factor Market Share by Region (2023-2028)
    Table 13. Glial Cell Line Derived Neurotrophic Factor Market Trends
    Table 14. Glial Cell Line Derived Neurotrophic Factor Market Drivers
    Table 15. Glial Cell Line Derived Neurotrophic Factor Market Challenges
    Table 16. Glial Cell Line Derived Neurotrophic Factor Market Restraints
    Table 17. Global Glial Cell Line Derived Neurotrophic Factor Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Glial Cell Line Derived Neurotrophic Factor Market Share by Players (2017-2022)
    Table 19. Global Top Glial Cell Line Derived Neurotrophic Factor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glial Cell Line Derived Neurotrophic Factor as of 2021)
    Table 20. Ranking of Global Top Glial Cell Line Derived Neurotrophic Factor Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Glial Cell Line Derived Neurotrophic Factor Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Glial Cell Line Derived Neurotrophic Factor Product Solution and Service
    Table 24. Date of Enter into Glial Cell Line Derived Neurotrophic Factor Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Type (2017-2022)
    Table 28. Global Glial Cell Line Derived Neurotrophic Factor Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Type (2023-2028)
    Table 30. Global Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Application (2017-2022)
    Table 32. Global Glial Cell Line Derived Neurotrophic Factor Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Application (2023-2028)
    Table 34. North America Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2023-2028) & (US$ Million)
    Table 44. GlaxoSmithKline Plc Company Detail
    Table 45. GlaxoSmithKline Plc Business Overview
    Table 46. GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Product
    Table 47. GlaxoSmithKline Plc Revenue in Glial Cell Line Derived Neurotrophic Factor Business (2017-2022) & (US$ Million)
    Table 48. GlaxoSmithKline Plc Recent Development
    Table 49. Treeway BV Company Detail
    Table 50. Treeway BV Business Overview
    Table 51. Treeway BV Glial Cell Line Derived Neurotrophic Factor Product
    Table 52. Treeway BV Revenue in Glial Cell Line Derived Neurotrophic Factor Business (2017-2022) & (US$ Million)
    Table 53. Treeway BV Recent Development
    Table 54. UniQure NV Company Detail
    Table 55. UniQure NV Business Overview
    Table 56. UniQure NV Glial Cell Line Derived Neurotrophic Factor Product
    Table 57. UniQure NV Revenue in Glial Cell Line Derived Neurotrophic Factor Business (2017-2022) & (US$ Million)
    Table 58. UniQure NV Recent Development
    Table 59. Research Programs/Design for This Report
    Table 60. Key Data Information from Secondary Sources
    Table 61. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Glial Cell Line Derived Neurotrophic Factor Market Share by Type: 2021 VS 2028
    Figure 2. GSK-812 Features
    Figure 3. LAUR-301 Features
    Figure 4. TW-002 Features
    Figure 5. AMT-090 Features
    Figure 6. Others Features
    Figure 7. Global Glial Cell Line Derived Neurotrophic Factor Market Share by Application in 2021 & 2028
    Figure 8. Amyotrophic Lateral Sclerosis Case Studies
    Figure 9. Brain Ischemia Case Studies
    Figure 10. Parkinson's Disease Case Studies
    Figure 11. Retinal Degeneration Case Studies
    Figure 12. Others Case Studies
    Figure 13. Glial Cell Line Derived Neurotrophic Factor Report Years Considered
    Figure 14. Global Glial Cell Line Derived Neurotrophic Factor Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Glial Cell Line Derived Neurotrophic Factor Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Glial Cell Line Derived Neurotrophic Factor Market Share by Region: 2021 VS 2028
    Figure 17. Global Glial Cell Line Derived Neurotrophic Factor Market Share by Players in 2021
    Figure 18. Global Top Glial Cell Line Derived Neurotrophic Factor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glial Cell Line Derived Neurotrophic Factor as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Glial Cell Line Derived Neurotrophic Factor Revenue in 2021
    Figure 20. North America Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. North America Glial Cell Line Derived Neurotrophic Factor Market Share by Country (2017-2028)
    Figure 22. United States Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Glial Cell Line Derived Neurotrophic Factor Market Share by Country (2017-2028)
    Figure 26. Germany Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Share by Region (2017-2028)
    Figure 34. China Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Japan Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. South Korea Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Southeast Asia Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. India Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Australia Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Glial Cell Line Derived Neurotrophic Factor Market Share by Country (2017-2028)
    Figure 42. Mexico Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Brazil Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Share by Country (2017-2028)
    Figure 46. Turkey Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Saudi Arabia Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. GlaxoSmithKline Plc Revenue Growth Rate in Glial Cell Line Derived Neurotrophic Factor Business (2017-2022)
    Figure 49. Treeway BV Revenue Growth Rate in Glial Cell Line Derived Neurotrophic Factor Business (2017-2022)
    Figure 50. UniQure NV Revenue Growth Rate in Glial Cell Line Derived Neurotrophic Factor Business (2017-2022)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline Plc
Treeway BV
UniQure NV
Frequently Asked Questions
Glial Cell Line Derived Neurotrophic Factor report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Glial Cell Line Derived Neurotrophic Factor report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Glial Cell Line Derived Neurotrophic Factor report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports